PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
An octakis-decyl-substituted Zn(II)-phthalocyanine (ZnODPc) was prepared by chemical synthesis and was shown to possess favorable photophysical properties to act as a photodynamic agent. Intravenous injection of ZnODPc incorporated into Cremophor emulsions (1.2 or 2.4 mg/kg) to Balb/c mice bearing a MS-2 fibrosarcoma resulted in an efficient and selective accumulation of the phthalocyanine in the tumor. Illumination of the ZnODPc-loaded neoplastic lesion at 24 h after injection caused tumor regression as a result of both intracellular and intravascular damage.
Michael J. Cook,Clara Fabris,Cristina Ometto,Denise A. Mayes,Giulio Jori,Jim McMurdo,Carla Milanesi, andDavid A. Russell
"Highly substituted phthalocyanine derivatives as potential photosensitizers for photodynamic therapy of tumors", Proc. SPIE 2078, Photodynamic Therapy of Cancer, (1 March 1994); https://doi.org/10.1117/12.168705
ACCESS THE FULL ARTICLE
INSTITUTIONAL Select your institution to access the SPIE Digital Library.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
The alert did not successfully save. Please try again later.
Michael J. Cook, Clara Fabris, Cristina Ometto, Denise A. Mayes, Giulio Jori, Jim McMurdo, Carla Milanesi, David A. Russell, "Highly substituted phthalocyanine derivatives as potential photosensitizers for photodynamic therapy of tumors," Proc. SPIE 2078, Photodynamic Therapy of Cancer, (1 March 1994); https://doi.org/10.1117/12.168705